CombiROC: An interactive web tool for selecting accurate marker combinations of omics data

Scientific Reports

Volumn 7, Issue , 2017, Pages

  Mazzara, Saveria ^a   Rossi, Riccardo L ^a   Grifantini, Renata ^a   Donizetti, Simone ^a   Abrignani, Sergio ^a,b   Bombaci, Mauro ^a  

^a Istituto Nazionale di Genetica Molecolare   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MICRORNA;

AREA UNDER THE CURVE; AUTOIMMUNE HEPATITIS; BLOOD; COMPUTER INTERFACE; GENETICS; GENOMICS; HUMAN; INTERNET; LYMPHOMA; METABOLISM; MYOTONIC DYSTROPHY; PROTEOMICS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

AREA UNDER CURVE; BIOMARKERS; GENOMICS; HEPATITIS, AUTOIMMUNE; HUMANS; INTERNET; LYMPHOMA; MICRORNAS; MYOTONIC DYSTROPHY; PROTEOMICS; ROC CURVE; SENSITIVITY AND SPECIFICITY; USER-COMPUTER INTERFACE;

EID: 85016551547     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep45477     Document Type: Article

References (31)

1. Pfaffl, M. W. Transcriptional biomarkers. Methods 59, 1-2 (2013).
2. Janvilisri, T., Suzuki, H., Scaria, J., Chen, J.-W. & Charoensawan, V. High-Throughput Screening for Biomarker Discovery. Dis. Markers 2015, 108064 (2015).
3. Sotiriou, C. & Piccart, M. J. Taking gene-expression profiling to the clinic: when will molecular signatures become relevant to patient care? Nat. Rev. Cancer 7, 545-553 (2007).
4. Kim, B. K. et al. The multiplex bead array approach to identifying serum biomarkers associated with breast cancer. Breast Cancer Res 11, R22 (2009).
5. Freydanck, M. K. et al. Two-marker combinations for preoperative discrimination of benign and malignant ovarian masses. Anticancer Res. 32, 2003-2008 (2012).
6. Panebianco, F. et al. The combination of four molecular markers improves thyroid cancer cytologic diagnosis and patient management. BMC Cancer 15, 918 (2015).
7. Su, Y.-L. et al. Combination of OipA, BabA, and SabA as candidate biomarkers for predicting Helicobacter pylori-related gastric cancer. Sci. Rep. 6, 36442 (2016).
8. Etzioni, R., Kooperberg, C., Pepe, M., Smith, R. & Gann, P. H. Combining biomarkers to detect disease with application to prostate cancer. Biostatistics 4, 523-38 (2003).
9. Hainard, A. et al. A combined CXCL10, CXCL8 and H-FABP panel for the staging of human African trypanosomiasis patients. PLoS Negl. Trop. Dis. 3, (2009).
10. Turck, N. et al. A multiparameter panel method for outcome prediction following aneurysmal subarachnoid hemorrhage. Intensive Care Med. 36, 107-115 (2010).
11. Fung, K. Y. C. et al. Blood-based protein biomarker panel for the detection of colorectal cancer. PLoS One 10, (2015).
12. Li, J., Zhang, Z., Rosenzweig, J., Wang, Y. Y. & Chan, D. W. Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. Clin. Chem. 48, 1296-1304 (2002).
13. Bombois, S. et al. A new decision tree combining Abeta 1-42 and p-Tau levels in Alzheimer's diagnosis. Curr. Alzheimer Res. 10, 357-364 (2013).
14. Zhang, F., Deng, Y. & Drabier, R. Multiple biomarker panels for early detection of breast cancer in peripheral blood. Biomed Res. Int. 2013, 781618 (2013).
15. Buyse, M. et al. Integrating biomarkers in clinical trials. Expert Rev. Mol. Diagn. 11, 171-182 (2011).
16. de Gramont, A. et al. Pragmatic issues in biomarker evaluation for targeted therapies in cancer. Nat. Rev. Clin. Oncol. 12, 197-212 (2015).
17. Kramar, A., Faraggi, D., Fortuné, A. & Reiser, B. mROC: A computer program for combining tumour markers in predicting disease states. Comput. Methods Programs Biomed. 66, 199-207 (2001).
18. Robin, X. et al. Bioinformatics for protein biomarker panel classification: what is needed to bring biomarker panels into in vitro diagnostics? Expert Rev. Proteomics 6, 675-689 (2009).
19. Xia, J., Broadhurst, D. I., Wilson, M. & Wishart, D. S. Translational biomarker discovery in clinical metabolomics: An introductory tutorial. Metabolomics 9, 280-299 (2013).
20. Zingaretti, C. et al. Identification of New Autoantigens by Protein Array Indicates a Role for IL4 Neutralization in Autoimmune Hepatitis. Mol. Cell. Proteomics 11, 1885-1897 (2012).
21. Perfetti, A. et al. Plasma microRNAs as biomarkers for myotonic dystrophy type 1. Neuromuscul. Disord. 24, 509-515 (2014).
22. Mazzara, S. et al. Two of them do it better: Novel serum biomarkers improve autoimmune hepatitis diagnosis. PLoS One 10, e0137927 (2015).
23. Baraniskin, A. et al. Identification of microRNAs in the cerebrospinal fluid as biomarker for the diagnosis of glioma. Neuro. Oncol. 14, 29-33 (2012).
24. van den Berg, R. a., Hoefsloot, H. C. J., Westerhuis, J. a., Smilde, A. K. & van der Werf, M. J. Centering, scaling, and transformations: improving the biological information content of metabolomics data. BMC Genomics 7, 142 (2006).
25. Eriksson, L. Multi- and megavariate data analysis, Part 1: Basic principles and applications. (2006).
26. Team, R. D. C. & R Development Core Team, R. R: A Language and Environment for Statistical Computing. R Found. Stat. Comput. 1, 409 (2005).
27. Chang, W., Cheng, J., Allaire, J., Xie, Y. & McPherson, J. shiny: Web Application Framework for R. R Packag. version 0.11 1 (2016).
28. Highsoft AS, H. J. http://www.highcharts.com/about.
29. Veer, V. L. et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 415, 530-536 (2002).
30. Metsalu, T. & Vilo, J. ClustVis: A web tool for visualizing clustering of multivariate data using Principal Component Analysis and heatmap. Nucleic Acids Res. 43, W566-W570 (2015).
31. Spitzer, M., Wildenhain, J., Rappsilber, J. & Tyers, M. BoxPlotR: a web tool for generation of box plots. Nat. Methods 11, 121-2 (2014).